Infusive Compounding Global Equities ETF
JOYY
JOYY was delisted on the 10th of June, 2022.
0 hedge funds and large institutions have $0 invested in Infusive Compounding Global Equities ETF in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 4 closing their positions.
100% less funds holding
Funds holding: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $7.92M → $0 (-$7.92M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3.55M |
| 2 |
Jane Street
New York
|
-$2.71M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.55M |
| 4 |
IAM
Infusive Asset Management
New York
|
-$108K |
JOYY Hedge Fund Activity: Q2 2022 in Review
0 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Infusive Compounding Global Equities ETF (JOYY) for Q2 2022, worth a combined $0 — down 100% from $7.92M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of JOYY and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $3.55M sold.
- 0 institutional investors held Infusive Compounding Global Equities ETF (JOYY) as of Q2 2022, down from 4 in Q1 2022.
- Funds reported $0 of Infusive Compounding Global Equities ETF stock for Q2 2022, down 100% quarter-over-quarter.
- 0 funds opened new Infusive Compounding Global Equities ETF positions in Q2 2022 and 4 closed out, a net change of -4 holders.
- The largest Infusive Compounding Global Equities ETF seller in Q2 2022 was UBS Group, an estimated $3.55M sold.
Based on aggregated 13F filings for Q2 2022.